Core–shell microbead-based 3D vascularized glioma tumor model for effective drug testing
Biofabrication · 2025
DOI: 10.1088/1758-5090/adebb5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biofabrication, 2025. Verfasst von Xiuxiu Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine and Healthcare Research Center, Tsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua University, Shenzhen 518055, People's Republ…. Hauptthemen laut MEDLINE: Glioma, Microspheres, Models, Biological, Antineoplastic Agents. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Major Science and Technology Project of Shenzhen, Research and Development Program of Guangdong Province, Shenzhen Science and Technology Major Project.
Abstract (Originalsprache)
The 3D hydrogel-based tumor model demonstrates significant potential in replicating the physiological characteristics of in vivo tumor environments for mechanistic studies and drug testing. However, the challenge persists in accurately mimicking a vascularized microtumor with a compartmentalized structure in a controlled, heterogeneous, and high-throughput manner. This study introduces a vascularized 3D tumor model that incorporates an endothelial cell (EC) barrier, created by encapsulating glioma cells and human umbilical vein endothelial cells (HUVECs) within the core (6% gelatin) and shell (10% GelMa) of core–shell microbeads, respectively. Upon culture, the tumor cells develop spheroids within the liquid core, while the HUVECs in the shell migrate and adhere to the GelMa surface, ultimately forming an EC barrier. This 3D microengineered tumor model exhibits angiogenesis in solid tumor spheroids, effectively mirroring the in vivo structure and providing relevant biochemical and biophysical properties. Notably, in comparison to 2D cell cultures, the vascularized tumor model shows significantly higher half-maximal inhibitory concentrations for the anticancer drug doxorubicin. Collectively, these findings highlight the considerable potential of engineered 3D tumor models in drug testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Precision Medicine and Healthcare Research Center, Tsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua University, Shenzhen 518055, People's Republic of China.
- Center for Bio-intelligent Manufacturing and Living Matter Bioprinting, Research Institute of Tsinghua University in Shenzhen, Tsinghua University, Shenzhen 518057, People's Republic of China.
- Department of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, United States of America.
- Department of Mechanical and Energy Engineering, Southern University of Science and Technology, Shenzhen, People's Republic of China.
- Research and Development Department (R&D), Qingyuanzhixin (shenzhen) Biotechnology Co., LTD, Shenzhen, People's Republic of China.
Förderung
- Major Science and Technology Project of Shenzhen
- Research and Development Program of Guangdong Province
- Shenzhen Science and Technology Major Project
Zitieren
APA
Zhang, X., Wang, Z., Liu, Z., Zhan, Z., Chen, J., & Xu, T. (2025). Core–shell microbead-based 3D vascularized glioma tumor model for effective drug testing. Biofabrication. https://doi.org/10.1088/1758-5090/adebb5
Vancouver
Zhang X, Wang Z, Liu Z, Zhan Z, Chen J, Xu T. Core–shell microbead-based 3D vascularized glioma tumor model for effective drug testing. Biofabrication. 2025. doi:10.1088/1758-5090/adebb5
BibTeX
@article{Zhang2025,
author = {Zhang, Xiuxiu and Wang, Zixian and Liu, Zeyang and Zhan, Zhen and Chen, Jianwei and Xu, Tao},
title = {Core–shell microbead-based 3D vascularized glioma tumor model for effective drug testing},
journal = {Biofabrication},
year = {2025},
doi = {10.1088/1758-5090/adebb5}
}
EUVIMED